HRT Monitoring and Follow-Up: What Good Care Looks Like After You Start

HRT monitoring and follow-up should be simple, regular, and built around how you feel — not a blood test you have to chase.

For most women on menopause hormone therapy, good care means a check-in about 3 months after you start or change a dose, then at least once a year if things are steady — with a faster follow-up if you get side effects, unusual bleeding, or no relief. Routine estrogen and progesterone blood tests usually aren't needed. The exception is testosterone, which always requires monitoring.

What varies enormously is how different providers actually deliver that follow-up. Some run proper video visits and can order your labs. Others rely on unlimited messaging. A few make it harder than it should be. This page breaks down the standard of care, explains which blood tests actually matter, and compares how real providers measure up.

Your HRT follow-up at a glance

This lines up with how menopause clinicians commonly review hormone therapy. The UK's NICE guideline spells it out plainly — review at 3 months, then yearly unless there's a reason to check sooner. The Menopause Society and Mayo Clinic make the same core point: hormone therapy should be reviewed regularly and tailored to you, not set on autopilot.

What does HRT monitoring and follow-up actually mean?

HRT monitoring means checking three things over time: is the treatment easing your symptoms, is it causing side effects, and does the benefit still outweigh the risk for you. Good follow-up also makes it easy to adjust your dose, switch the form you use, handle bleeding or side effects, and know when you need in-person care. It is not "take hormones and disappear."

Here's the mindset shift that helps most: HRT isn't a one-time fix you set and forget. Your body changes. Your symptoms change. The dose that's perfect at month three might need a small tweak at month nine. That's normal. The whole point of follow-up is to keep the plan matched to you as you go — and to catch the rare problem early.

How often should HRT be reviewed after you start?

A strong, practical standard is a follow-up around 3 months after you start HRT or change your dose, then at least once a year if everything is steady. You should follow up sooner if your symptoms don't improve, side effects show up, bleeding worries you, or your health changes. NICE recommends this 3-month-then-yearly rhythm, and it's widely used in menopause care.

Why three months? Because hormones take time to work. Hot flashes and night sweats often ease within a few weeks, but mood, sleep, and vaginal symptoms can take up to about three months to settle. Checking too early can make a working dose look like a failure. Three months gives a fair read.

The simple HRT follow-up timeline

What should your first HRT follow-up cover?

Your first follow-up — usually around three months — answers one question: is this still the right treatment, dose, and form for you? It should review your symptom relief, side effects, any bleeding, how you're using the medication, and whether you need a change, labs, or in-person care.

Bring honest notes. The more specific you are, the better the visit.

Your 3-month review checklist

Use this to prep — and to judge whether your provider is actually paying attention:

What a clinician might change after this review

• Raise or lower the dose
• Switch the route — for example, from a pill to a patch
• Change the type of estrogen
• Adjust your progesterone plan
• Add vaginal estrogen for local dryness or urinary symptoms
• Switch to a non-hormone option if HRT isn't a good fit
• Refer you for in-person or specialist care

Do you need blood tests to monitor HRT?

For most women on standard menopause HRT, the honest answer is no — you usually don't need routine hormone blood tests to guide treatment. Doctors mainly judge whether HRT is working by your symptoms, not by a number on a lab report. Blood tests still matter in specific situations, and they matter most for testosterone.

This surprises a lot of people, because some clinics market frequent "hormone level" testing as the gold standard. It isn't, for routine menopause care. Hormone levels swing from day to day and even hour to hour, which makes a single blood draw a shaky guide. StatPearls notes that routine testing of FSH, estradiol, or progesterone isn't traditionally recommended or supported by ACOG to monitor or direct menopause therapy — treatment response is judged by symptoms, not by chasing a target number.

So if a provider doesn't make you get blood drawn every few months for standard estrogen, that's not laziness — for estrogen, it can actually match the guidelines. This plays out differently from provider to provider: Midi can order labs and screenings when a clinician decides they're useful, Winona doesn't require hormone blood tests and adjusts based on symptoms, and Sesame includes basic lab work if your provider orders it.

Hormone labs are not the same as safety labs

This is the distinction that clears up most of the confusion:

The big exception: testosterone

If testosterone is added to your HRT, that does call for blood tests. Two honest facts: there is no FDA-approved testosterone product made for menopausal symptoms in women, so any use is off-label or compounded and needs real clinician oversight. Guidance from ACOG and an international expert panel points to a baseline testosterone level before you start, a recheck a few weeks after to make sure levels land in a safe female range, then ongoing monitoring to keep levels healthy long-term.

When labs are more likely to matter for you

• You're under 45 with menopause-type symptoms
• Early (premature) menopause is suspected
• Your symptoms could be thyroid-related
• You have unexplained fatigue
• You have heart or metabolic risk concerns
• You have a complex medical history or lots of medications
• Your provider or insurance specifically requires them

What's the difference between symptom-led and lab-led monitoring?

Symptom-led monitoring asks whether you feel better, tolerate the treatment, and remain a good candidate for your current dose. Lab-led monitoring tries to adjust treatment mainly from hormone numbers, which is usually not the standard approach for typical menopause HRT. For most women, how you feel is the better guide.

That's not anti-science — it's the opposite. Chasing a "perfect" estrogen number can lead to over-treating someone who already feels great, or under-treating someone whose number looks fine but who's still miserable. Mayo Clinic's guidance leans on individualized care and regular benefit-versus-risk reviews, not a target lab value. Labs are a tool you reach for when there's a specific question — not a scoreboard you check every month.

What symptoms should make you follow up sooner?

Don't wait for your yearly review if your symptoms get worse, side effects are hard to live with, or bleeding seems outside the normal settling-in window. Some symptoms need urgent care, not an online message — including chest pain, trouble breathing, one-sided weakness, or signs of a blood clot. When in doubt, get seen.

How should follow-up change based on the form of HRT you use?

The form matters because patches, pills, creams, gels, and vaginal estrogen each have their own practical issues and risk considerations. Follow-up should confirm the route still fits your symptoms, your risk profile, and your ability to use it correctly. The right form is the one you'll actually use well.

How do FDA-approved and compounded HRT differ for monitoring?

The day-to-day monitoring is similar — both rely on symptom and safety follow-up — but the key difference is regulatory. FDA-approved hormones have been reviewed by the FDA for safety, effectiveness, and quality. Compounded hormones are mixed by a pharmacy for an individual patient and are not FDA-approved; the FDA does not verify a compounded drug's safety, effectiveness, or quality before it's sold. A good provider should tell you clearly which type you're getting.

Why this matters for you: compounded products have a legitimate place — for example, when someone can't use an FDA-approved option, or needs a dose or form that isn't commercially made. But ACOG advises that there's a lack of high-quality safety and efficacy data for custom-compounded "bioidentical" hormone therapy, and that it generally shouldn't be the routine choice when an FDA-approved formulation would work. "Bioidentical" is a marketing term, not an FDA category — so don't read it as "safer" or "proven." If you want FDA-approved hormones specifically, that's worth telling your provider up front. You can dig deeper in our FDA-approved vs. compounded HRT guide.

Does online HRT actually monitor you — or just mail pills?

The good telehealth providers genuinely monitor you, but their models are very different. Some run scheduled video visits and can order your labs and screenings. Others use unlimited text messaging and treat hormone labs as optional, which is reasonable for standard estrogen but lighter for testosterone or anyone who wants proactive check-ins.

HRT follow-up comparison

Verified from each provider's own pages on June 15, 2026. Pricing, states, and policies change — confirm on the provider's site before you sign up.

Best for structured monitoring and labs: Midi Health

If you want scheduled clinical follow-up, the ability to get labs and screenings ordered for you, insurance, or FDA-approved hormones, Midi Health is the strongest fit. Its model is built around recurring video visits plus messaging, and its clinicians can order lab work, imaging, and mammograms when they're needed.

Midi accepts most PPO insurance plans and operates in all 50 states. Paying cash, the first visit is $250 and follow-ups are $150, while most insured patients pay around $50 out of pocket per visit. Its clinicians are trained in midlife care, and follow-up visits exist specifically to track your response and adjust your plan over time.

The honest downside: Midi is not the cheapest option, and it does not work with Medicaid, Medi-Cal, or Medicare (though Medicare beneficiaries can pay out of pocket). If a low, flat monthly price is your top priority, Winona (from about $39–$89/month) or a Sesame subscription will likely cost you less.

Best for convenience on standard estrogen: Winona

If you want unlimited check-ins without scheduling appointments and a predictable cash price, Winona is a strong, convenient option. It includes free, unlimited follow-up messaging with a licensed clinician, ships to your door, and lets you pause or cancel.

A point worth clearing up: Winona is not "compounded only." Its estrogen patches, estrogen tablets, and progesterone capsules are FDA-approved, while its estrogen and progesterone body creams are compounded (not FDA-approved as finished products). Winona doesn't require hormone blood tests and adjusts your dose based on your symptoms — which actually aligns with clinical guidelines for standard estrogen. Medication starts around $39/month for progesterone, $54 for estrogen tablets, and $89 for its popular estrogen-cream-plus-progesterone combo. Cash-pay, HSA/FSA eligible. Winona earns about 4.6 out of 5 on Trustpilot across more than 7,000 ratings.

Note: care is text-based with no video visits, and Winona is available in a limited (but growing) set of states — check its current list before committing.

Best for provider choice with labs included: Sesame

If you want to pick your own clinician and have basic labs included when they're ordered, Sesame is worth a look. Its menopause care is a subscription — you choose a provider, get video visits plus unlimited messaging, and prescriptions are sent same-day to your local pharmacy. Hormone options are FDA-approved generics.

Two things to know: Sesame doesn't bill insurance, and medication costs aren't included in the subscription price. Basic lab work (CBC, A1c, thyroid, lipid panel, metabolic panel) is included when your provider orders it, with some state exceptions. Full refund if you cancel at least 3 hours before your initial visit; after the visit, the first month isn't refundable — confirm at checkout.

Hers and Inner Balance (Oestra): promising, but verify first

Hers now offers menopause HRT online — oral and transdermal estradiol and progesterone, with oral plans starting around $79/month and patches around $134/month on a 12-month plan, plus unlimited access to providers who focus on menopause. We're keeping Hers in a "verify first" spot only because we still want to confirm its state availability, cancellation and refund terms, and exact follow-up cadence before naming it a monitoring winner.

Inner Balance (Oestra) offers a compounded hormone cream (not FDA-approved as a finished product), with advertised pricing around $199/month for six months, then about $99.50/month, and a money-back guarantee that carries conditions. Because it's compounded and the refund terms have specific limits, verify the current details at checkout before you commit.

Telehealth vs. in-person HRT monitoring — which is right for you?

For most standard menopause HRT, telehealth monitoring is appropriate and safe, and the better platforms order labs when they're needed. In-person care still has the edge for complex situations — a significant heart or clot history, anyone needing a physical exam or imaging, or labs that come back abnormal. Plenty of women reasonably use both.

Be honest with yourself about your situation. If any of these describe you, lean toward in-person or hybrid care:

• A personal history of breast or hormone-related cancer
• A high risk of blood clots, or a past clot
• Heart disease that isn't well controlled
• Heavy or unexplained bleeding
• A need for a physical exam or imaging
• Symptoms that are severe or confusing

If that's you, telehealth alone probably isn't enough. For the in-between cases, our guides on HRT side effects and HRT blood tests can help you figure out what to ask.

What should you ask an online HRT provider before you pay?

Before you pay, ask how follow-ups work, whether dose changes cost extra, whether labs are included, which pharmacy fills your prescription, whether the medication is FDA-approved or compounded, and how cancellation works. A provider that can't answer these clearly shouldn't be treated as a low-risk choice. Save yourself the headache and ask up front.

The 12-question provider checklist

We built this from the complaints we see most often. Screenshot it:

What real customers say about follow-up

Reviews are useful for one thing here: judging the experience of follow-up — how easy it is to reach someone and get a change made. They are not proof that a treatment works or is safe for you. We only use real, attributable review data, and we read the negative reviews too.

The clearest signal we found is Winona's review profile: about 4.6 out of 5 on Trustpilot from more than 7,000 ratings, with the company replying to the large majority of negative reviews — most within 24 hours. The most common complaints aren't about safety; they're about confusion with the subscription and occasional shipping delays. Sesame holds roughly a 4.5 out of 5 on Trustpilot. Midi's reviews are more mixed, which tracks with its more involved, insurance-based model. Read recent reviews yourself before you choose — patterns shift over time.

How we verified this

We compared providers on follow-up access, dose-adjustment clarity, lab and screening approach, pricing transparency, cancellation friction, and whether they're clear about FDA-approved versus compounded medication. Medical claims were checked against authoritative sources; commercial claims were checked against each provider's own pages and current public reviews.

What we actually verified (June 15, 2026): the 3-month and yearly review standard; the exact bleeding-timing windows; that routine hormone labs aren't generally needed for standard menopause HRT; how testosterone is monitored in women; from each provider's own pages — Midi's pricing ($250/$150/~$50), insurance, all-50-states reach, and lab-ordering; Winona's mixed FDA-approved/compounded lineup, no-required-labs model, cash pricing ($39–$89), and that it doesn't prescribe testosterone; Sesame's subscription model, FDA-approved generics, and included-labs-if-ordered policy. Still worth confirming at checkout: Hers' state availability, cancellation terms, and follow-up cadence; Inner Balance/Oestra's current pricing and refund window; and each provider's live state coverage.

HRT monitoring and follow-up FAQ